COMP <GO>
CVR vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Chicago Rivet & Machine Co. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CVR 1
— TMO 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $10.90 (+8.35%) • MKT CAP: $10.5M
roic
-5.50%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 14.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -5.50% | 9.30% | -14.80 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.66% | 2.40% | -14.06 | TMO | /fcf-yield <GO> |
| Operating Margin | -4.30% | 17.40% | -21.70 | TMO | /operating-margins <GO> |
| Net Profit Margin | -3.90% | 15.10% | -19.00 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 3.30% | 3.90% | -0.60 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.10% | 0.24% | +0.86 | CVR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.22 | 4.50 | -0.28 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 8/9 | -6.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.6 | 62.9 | -4.29 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.5M | $262.22B | -$262.21B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVR REV | TMO REV | CVR GROSS % | TMO GROSS % | CVR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $27.9M | $44.56B | 14.8% | — | -$1.2M | $6.29B |
| FY 2024 | $27.0M | $42.88B | 3.9% | — | -$804.8K | $7.27B |
| FY 2023 | $31.5M | $42.86B | — | — | -$1.9M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVR // BETA —
TMO // BETA 0.94